Caveolin-1-deficient aortic smooth muscle cells show cell autonomous abnormalities in proliferation, migration, and endothelin-based signal transduction

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 290, Issue 6, 2006, Pages

  Hassan, Ghada S ^a   Williams, Terence M ^a   Frank, Philippe G ^a,b   Lisanti, Michael P ^a,b,c  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c UNIVERSITY OF GENOA   (Italy)

Author keywords

Calcium response; Caveolae; Caveolin; Endothelin receptors; Neointimal hyperplasia; Vascular disease

Indexed keywords

CAVEOLIN 1; CYCLIN DEPENDENT KINASE INHIBITOR; ENDOTHELIN 1;

ANIMAL CELL; ARTICLE; CELL MIGRATION; CELL NUCLEUS MEMBRANE; CELL PROLIFERATION; GENE EXPRESSION; HYPERPLASIA; INTIMA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; WOUND HEALING;

ANIMALS; ANTIMETABOLITES; AORTA; BROMODEOXYURIDINE; CALCIUM; CAVEOLIN 1; CELL CYCLE PROTEINS; CELL MOVEMENT; CELL PROLIFERATION; CELL SEPARATION; CELLS, CULTURED; ENDOTHELIN-1; ENDOTHELINS; ENZYME ACTIVATION; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOBLOTTING; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROSCOPY, CONFOCAL; MITOGEN-ACTIVATED PROTEIN KINASE 1; MUSCLE, SMOOTH, VASCULAR; SIGNAL TRANSDUCTION; WOUND HEALING;

EID: 33744909809     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.01161.2005     Document Type: Article

References (52)

1. Alberts B, Lewis J, Raff M, Roberts K, and Watson JD. Molecular Biology of the Cell. New York: Garland, 1994.
2. Babaei S, Picard P, Ravandi A, Monge JC, Lee TC, Cernacek P, and Stewart DJ. Blockade of endothelin receptors markedly reduces atherosclerosis in LDL receptor-deficient mice: role of endothelin in macrophage foam cell formation. Cardiovasc Res 48: 158-167, 2000.
3. 2+ entry dependent on TRPC1. Circ Res 93: 839-847, 2003.
4. Bkaily G, Choufani S, Hassan G, El-Bizri N, Jacques D, and D'Orleans-Juste P. Presence of functional endothelin-1 receptors in nuclear membranes of human aortic vascular smooth muscle cells. J Cardiovasc Pharmacol 36: S414-S417, 2000.
5. Bkaily G, Massaad D, Choufani S, Jacques D, and D'Orleans-Juste P. Role of endothelin-1 receptors in the sarcolemma membrane and the nuclear membrane in the modulation of basal cytosolic and nuclear calcium levels in heart cells. Clin Sci (Lond) 103 Suppl 48: 141S-147S, 2002.
6. Bkaily G, Pothier P, D'Orleans-Juste P, Simaan M, Jacques D, Jaalouk D, Belzile F, Hassan G, Boutin C, Haddad G, and Neugebauer W. The use of confocal microscopy in the investigation of cell structure and function in the heart, vascular endothelium and smooth muscle cells. Mol Cell Biochem 172: 171-194, 1997.
7. Capozza F, Williams TM, Schubert W, McClain S, Bouzahzah B, Sotgia F, and Lisanti MP. Absence of caveolin-1 sensitizes mouse skin to carcinogen-induced epidermal hyperplasia and tumor formation. Am J Pathol 162: 2029-2039, 2003.
8. Chun M, Liyanage UK, Lisanti MP, and Lodish HF. Signal transduction of a G protein-coupled receptor in caveolae: colocalization of endothelin and its receptor with caveolin. Proc Natl Acad Sci USA 91: 11728-11732, 1994.
9. Clozel M and Clozel JP. Effects of endothelin on regional blood flows in squirrel monkeys. J Pharmacol Exp Ther 250: 1125-1131, 1989.
10. Cohen AW, Hnasko R, Schubert W, and Lisanti MP. Role of caveolae and caveolins in health and disease. Physiol Rev 84: 1341-1379, 2004.
11. Cohen AW, Park DS, Woodman SE, Williams TM, Chandra C, Shirani J, Pereira De Souza A, Kitsis RN, Russell RG, Weiss LM, Tang B, Jelicks LA, Factor SM, Shtutin V, Tanowitz HB, and Lisanti MP. Caveolin-1-deficient mice develop cardiac hypertrophy and show hyper-activation of the p42/44 MAP kinase cascade in areas of interstitial fibrosis and isolated cardiac fibroblasts. Am J Physiol Cell Physiol 284: C457-C474, 2003.
12. D'Orleans-Juste P, Labonte J, Bkaily G, Choufani S, Plante M, and Honore JC. Function of the endothelinB receptor in cardiovascular physiology and pathophysiology. Pharmacol Ther 95: 221-238, 2002.
13. Drab M, Verkade P, Elger M, Kasper M, Lohn M, Lauterbach B, Menne J, Lindschau C, Mende F, Luft FC, Schedl A, Haller H, and Kurzchalia TV. Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice. Science 293: 2449-2452, 2001.
14. Dreja K, Voldstedlund M, Vinten J, Tranum-Jensen J, Hellstrand P, and Sward K. Cholesterol depletion disrupts caveolae and differentially impairs agonist-induced arterial contraction. Arterioscler Thromb Vasc Biol 22: 1267-1272, 2002.
15. Engelman JA, Wycoff CC, Yasuhara S, Song KS, Okamoto T, and Lisanti MP. Recombinant expression of caveolin-1 in oncogenically transformed cells abrogates anchorage-independent growth. J Biol Chem 272: 16374-16381, 1997.
16. Frank PG, Lee H, Park DS, Tandon NN, Scherer PE, and Lisanti MP. Genetic ablation of caveolin-1 confers protection against atherosclerosis. Arterioscler Thromb Vasc Biol 24: 98-105, 2004.
17. Frank PG and Lisanti MP. Caveolin-1 and caveolae in atherosclerosis: differential roles in fatty streak formation and neointimal hyperplasia. Curr Opin Lipidol 15: 523-529, 2004.
18. 2+ entry channels involved in contractions of rat aorta induced by endothelin-1, noradrenaline, and vasopressin. J Cardiovasc Pharmacol 40: 265-276, 2002.
19. Galbiati F, Razani B, and Lisanti MP. Emerging themes in lipid rafts and caveolae. Cell 106: 403-411, 2001.
20. Galbiati F, Volonte D, Engelman JA, Watanabe G, Burk R, Pestell R, and Lisanti MP. Targeted down-regulation of caveolin-1 is sufficient to drive cell transformation and hyperactivate the p42/44 MAP kinase cascade. EMBO J 17: 6633-6648, 1998.
21. Galie N, Manes A, and Branzi A. The endothelin system in pulmonary arterial hypertension. Cardiovasc Res 61: 227-237, 2004.
22. 2+-permeable channels in rabbit cerebral cortex arterioles. J Physiol 514: 843-856, 1999.
23. Gunther S, Alexander RW, Atkinson WJ, and Gimbrone MA Jr. Functional angiotensin II receptors in cultured vascular smooth muscle cells. J Cell Biol 92: 289-298, 1982.
24. Hassan GS, Jasmin JF, Schubert W, Frank PG, and Lisanti MP. Caveolin-1 deficiency stimulates neointima formation during vascular injury. Biochemistry 43: 8312-8321, 2004.
25. Hua H, Munk S, and Whiteside CI. Endothelin-1 activates mesangial cell ERK1/2 via EGF-receptor transactivation and caveolin-1 interaction. Am J Physiol Renal Physiol 284: F303-F312, 2003.
26. Ishizaka N, Griendling KK, Lassegue B, and Alexander RW. Angiotensin II type 1 receptor: relationship with caveolae and caveolin after initial agonist stimulation. Hypertension 32: 459-466, 1998.
27. Jacks T, Remington L, Williams BO, Schmitt EM, Halachmi S, Bronson RT, and Weinberg RA. Tumor spectrum analysis in p53-mutant mice. Curr Biol 4: 1-7, 1994.
28. Kobayashi T, Miyauchi T, Iwasa S, Sakai S, Fan J, Nagata M, Goto K, and Watanabe T. Corresponding distributions of increased endothelin-B receptor expression and increased endothelin-1 expression in the aorta of apolipoprotein E-deficient mice with advanced atherosclerosis. Pathol Int 50: 929-936, 2000.
29. Koleske AJ, Baltimore D, and Lisanti MP. Reduction of caveolin and caveolae in oncogenically transformed cells. Proc Natl Acad Sci USA 92: 1381-1385, 1995.
30. Lee H, Park DS, Razani B, Russell RG, Pestell RG, and Lisanti MP. Caveolin-1 mutations (P132L and null) and the pathogenesis of breast cancer: caveolin-1 (P132L) behaves in a dominant-negative manner and caveolin-1 (-/-) null mice show mammary epithelial cell hyperplasia. Am J Pathol 161: 1357-1369, 2002.
31. Lévy BMJP. Circulation. In: Anatomie et physiologie humaines. Éditions du Renouveau, edited by E. M. M. 1993, p. 198-210.
32. Masaki T. The discovery of endothelins. Cardiovasc Res 39: 530-533, 1998.
33. Moreland S, McMullen DM, Delaney CL, Lee VG, and Hunt JT. Venous smooth muscle contains vasoconstrictor ETB-like receptors. Biochem Biophys Res Commun 184: 100-106, 1992.
34. Okamoto Y, Ninomiya H, Miwa S, and Masaki T. Cholesterol oxidation switches the internalization pathway of endothelin receptor type A from caveolae to clathrin-coated pits in Chinese hamster ovary cells. J Biol Chem 275: 6439-6446, 2000.
35. Park DS, Lee H, Frank PG, Razani B, Nguyen AV, Parlow AF, Russell RG, Hulit J, Pestell RG, and Lisanti MP. Caveolin-1-deficient mice show accelerated mammary gland development during pregnancy, premature lactation, and hyperactivation of the Jak-2/STAT5a signaling cascade. Mol Biol Cell 13: 3416-3430, 2002.
36. Pernow J, Bohm F, Johansson BL, Hedin U, and Ryden L. Enhanced vasoconstrictor response to endothelin-B-receptor stimulation in patients with atherosclerosis. J Cardiovasc Pharmacol 36: S418-S420, 2000.
37. Peterson TE, Guicciardi ME, Gulati R, Kleppe LS, Mueske CS, Mookadam M, Sowa G, Gores GJ, Sessa WC, and Simari RD. Caveolin-1 can regulate vascular smooth muscle cell fate by switching platelet-derived growth factor signaling from a proliferative to an apoptotic pathway. Arterioscler Thromb Vasc Biol 23: 1521-1527, 2003.
38. Ratz PH, Berg KM, Urban NH, and Miner AS. Regulation of smooth muscle calcium sensitivity: KCl as a calcium-sensitizing stimulus. Am J Physiol Cell Physiol 288: C769-C783, 2005.
39. Ray JL, Leach R, Herbert JM, and Benson M. Isolation of vascular smooth muscle cells from a single murine aorta. Methods Cell Sci 23: 185-188, 2001.
40. Razani B, Engelman JA, Wang XB, Schubert W, Zhang XL, Marks CB, Macaluso F, Russell RG, Li M, Pestell RG, Di Vizio D, Hou H Jr, Kneitz B, Lagaud G, Christ GJ, Edelmann W, and Lisanti MP. Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities. J Biol Chem 276: 38121-38138, 2001.
41. Razani B and Lisanti MP. Caveolin-deficient mice: insights into caveolar function and human disease. J Clin Invest 108: 1553-1561, 2001.
42. Razani B, Woodman SE, and Lisanti MP. Caveolae: from cell biology to animal physiology. Pharmacol Rev 54: 431-467, 2002.
43. Smart EJ, Graf GA, McNiven MA, Sessa WC, Engelmen JA, Scherer PE, Okamoto T, and Lisanti MP. Caveolins, liquid-ordered domains, and signal transduction. Mol Cell Biol 19: 7289-7304, 1999.
44. Somlyo A. Ultrastructure of the microvascular wall: functional correlations. In: Handbook of Physiology. The Cardiovascular System. Vascular Smooth Muscle. Bethesda, MD: Am. Physiol. Soc., 1980, sect. 2, vol. II, chapt. 2, p. 33-67.
45. Thyberg J. Caveolin-1 and caveolae act as regulators of mitogenic signaling in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 23: 1481-1483, 2003.
46. Ushio-Fukai M, Hilenski L, Santanam N, Becker PL, Ma Y, Griendling KK, and Alexander RW. Cholesterol depletion inhibits epidermal growth factor receptor transactivation by angiotensin II in vascular smooth muscle cells: role of cholesterol-rich microdomains and focal adhesions in angiotensin II signaling. J Biol Chem 276: 48269-48275, 2001.
47. Williams TM, Lee H, Cheung MW, Cohen AW, Razani B, Iyengar P, Scherer PE, Pestell RG, and Lisanti MP. Combined loss of INK4a and caveolin-1 synergistically enhances cell proliferation and oncogene-induced tumorigenesis: role of INK4a/Cav-1 in mammary epithelial cell hyperplasia. J Biol Chem 279: 24745-24756, 2004.
48. Williams TM, Medina F, Badano I, Hazan RB, Hutchinson J, Muller WJ, Chopra NG, Scherer PE, Pestell RG, and Lisanti MP. Caveolin-1 gene disruption promotes mammary tumorigenesis and dramatically enhances lung metastasis in vivo. Role of Cav-1 in cell invasiveness and matrix metalloproteinase (MMP-2/9) secretion. J Biol Chem 279: 51630-51646, 2004.
49. Yamaguchi T, Murata Y, Fujiyoshi Y, and Doi T. Regulated interaction of endothelin B receptor with caveolin-1. Eur J Biochem 270: 1816-1827, 2003.
50. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, and Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332: 411-415, 1988.
51. Zeidan A, Broman J, Hellstrand P, and Sward K. Cholesterol dependence of vascular ERK1/2 activation and growth in response to stretch: role of endothelin-1. Arterioscler Thromb Vasc Biol 23: 1528-1534, 2003.
52. Zhang W, Razani B, Altschuler Y, Bouzahzah B, Mostov KE, Pestell RG, and Lisanti MP. Caveolin-1 inhibits EGF-stimulated lamellopod extension and cell migration in metastatic mammary adenocarcinoma cells (MTLn3). Transformation suppressor effects of adenoviral-mediated gene delivery of caveolin-1. J Biol Chem 275: 20717-20725, 2000.